Biogen Inc
XHAM:IDP

Watchlist Manager
Biogen Inc Logo
Biogen Inc
XHAM:IDP
Watchlist
Price: 158.9 EUR 2.85% Market Closed
Market Cap: 23.1B EUR

Wall Street
Price Targets

IDP Price Targets Summary
Biogen Inc

Wall Street analysts forecast IDP stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDP is 157.19 EUR with a low forecast of 112.54 EUR and a high forecast of 234 EUR.

Lowest
Price Target
112.54 EUR
29% Downside
Average
Price Target
157.19 EUR
1% Downside
Highest
Price Target
234 EUR
47% Upside
Biogen Inc Competitors:
Price Targets
VCEL
Vericel Corp
39% Upside
CSL
CSL Ltd
40% Upside
MRSN
Mersana Therapeutics Inc
16% Upside
SPRY
ARS Pharmaceuticals Inc
158% Upside
EDT
Spectral Medical Inc
127% Upside
EXEL
Exelixis Inc
3% Upside
BAVA
Bavarian Nordic A/S
28% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
60% Upside

Revenue
Forecast

Revenue Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

5%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

2%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
19%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDP's stock price target?
Price Target
157.19 EUR

According to Wall Street analysts, the average 1-year price target for IDP is 157.19 EUR with a low forecast of 112.54 EUR and a high forecast of 234 EUR.

What is Biogen Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Back to Top